Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases.
Ontology highlight
ABSTRACT: Liver diseases represent a major global health issue, and currently, liver transplantation is the only viable alternative to reduce mortality rates in patients with end-stage liver diseases. However, scarcity of donor organs and risk of recidivism requiring a re-transplantation remain major obstacles. Hence, much hope has turned towards cell-based therapy. Hepatocyte-like cells obtained from embryonic stem cells or adult stem cells bearing multipotent or pluripotent characteristics, as well as cell-based systems, such as organoids, bio-artificial liver devices, bioscaffolds and organ printing are indeed promising. New approaches based on extracellular vesicles are also being investigated as cell substitutes. Extracellular vesicles, through the transfer of bioactive molecules, can modulate
SUBMITTER: Cernigliaro V
PROVIDER: S-EPMC7072646 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA